
 [
{
"symbol" : "524824",
"exchange" : "BOM",
"id": "14295282",
"t" : "524824",
"e" : "BOM",
"name" : "Bal Pharma Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524824"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524824"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524824"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "3.34%",
"annual" : "-0.32%",
"ttm" : "1.26%"
},
{
"title" : "Operating margin",
"recent_quarter" : "8.45%",
"annual" : "3.38%",
"ttm" : "5.36%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "6.22%",
"ttm" : "8.70%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-0.33%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "3.37%",
"ttm" : ""
}
]
, "c" : "+0.55",
"l" : "96.00",
"cp" : "0.58",
"ccol" : "chg",
"op" : "96.50",
"hi" : "96.65",
"lo" : "95.35",
"vo" : "1,090.00",
"avvo" : "",
"hi52" : "128.00",
"lo52" : "84.45",
"mc" : "1.37B",
"pe" : "37.93",
"fwpe" : "",
"beta" : "",
"eps" : "2.53",
"dy" : "1.04",
"ldiv" : "1.00",
"shares" : "14.17M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "14295282",
"name" : "Bal Pharma Ltd",
"t" : "524824",
"e" : "BOM",
"l" : "96.00",
"c" : "+0.55",
"mc" : "1.37B",
"cp" : "0.58",
"ccol" : "chg"
}
,
{
"id" : "679412034444482",
"name" : "Bajaj Healthcare Ltd",
"t" : "539872",
"e" : "BOM",
"l" : "378.75",
"c" : "0.00",
"mc" : "2.61B",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "5262084",
"name" : "Marksans Pharma Limited",
"t" : "MARKSANS",
"e" : "NSE",
"l" : "38.60",
"c" : "-0.20",
"mc" : "15.74B",
"cp" : "-0.52",
"ccol" : "chr"
}
,
{
"id" : "7853362",
"name" : "Shasun Chemicals \u0026 Drugs Limited",
"t" : "SHASUNPHAR",
"e" : "NSE",
"l" : "431.00",
"c" : "",
"mc" : "28.99B",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "14759050",
"name" : "Indoco Remedies Ltd",
"t" : "INDOCO",
"e" : "NSE",
"l" : "260.50",
"c" : "-2.10",
"mc" : "24.13B",
"cp" : "-0.80",
"ccol" : "chr"
}
,
{
"id" : "16546949",
"name" : "Lincoln Pharmaceuticals Ltd",
"t" : "531633",
"e" : "BOM",
"l" : "239.25",
"c" : "+9.05",
"mc" : "4.77B",
"cp" : "3.93",
"ccol" : "chg"
}
,
{
"id" : "723347",
"name" : "Ambalal Sarabhai Enterprises Ltd",
"t" : "500009",
"e" : "BOM",
"l" : "12.65",
"c" : "+0.44",
"mc" : "962.32M",
"cp" : "3.60",
"ccol" : "chg"
}
,
{
"id" : "8321085",
"name" : "Godavari Drugs Ltd",
"t" : "530317",
"e" : "BOM",
"l" : "35.65",
"c" : "+1.65",
"mc" : "268.46M",
"cp" : "4.85",
"ccol" : "chg"
}
,
{
"id" : "15627003",
"name" : "Trimurthi Ltd",
"t" : "536565",
"e" : "BOM",
"l" : "8.00",
"c" : "0.00",
"mc" : "64.80M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "6886745",
"name" : "Twilight Litaka Pharma Ltd",
"t" : "TWILITAKA",
"e" : "NSE",
"l" : "0.00",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "677368",
"name" : "Fulford (India) Limited (Parent)",
"t" : "506803",
"e" : "BOM",
"l" : "2,362.50",
"c" : "",
"mc" : "9.21B",
"cp" : "",
"ccol" : ""
}
]
, "summary" : [{
"address": "Four Mangoe Lane Surendra Mohan Ghosh Sarani, BANGALORE, 560052, India",
"phone": "+91-80-41379500",
"fax": "+91-80-22354057",
"url": "http:\u002F\u002Fwww.balpharma.com\u002F",
"overview" : "Bal Pharma Limited is a holding company. The Company is a pharmaceutical company, which is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). It specializes in prescription drugs, generic, over-the-counter (OTC) products, intravenous infusion and bulk actives. The Company is also engaged in finished formulations and ayurvedic businesses. It offers APIs, including anti histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment and others. It offers a range of products covering dosage forms, such as tablets, capsules, syrups, suspensions, ophthalmic, creams and ointments to various markets. Its product range also includes ANARSHA, AYURFINE and others. It caters to both domestic and international markets. Its API\u0027s are exported to Europe, Far East, Latin America, Africa, the Middle East and other world markets."
} ]
, "management" : [
{
"name" : "Akash Mathur",
"title" : "Chief Executive Officer"
}
,
{
"name" : "Shailesh D. Siroya",
"age" : "45",
"title" : "Managing Director, Executive Director"
}
,
{
"name" : "S. Prasanna",
"age" : "64",
"title" : "Whole time Director"
}
,
{
"name" : "Sarika Bhandari",
"title" : "Additional Director"
}
,
{
"name" : "Promod S. Kumar",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "G. S. R. Subba Rao",
"age" : "75",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
